GAS6 and neoplasm: Collectively, these results establish the 3‐gene (ENAH, AXL and GAS6) expression signature as a prognostic indicator, hallmark of an aggressive disease in PDAC and LUSC patients and strengthen the clinical relevance of the hMENA expression pattern analysis in both tumor cells and CAFs.